Skip to main content

Table 1 Findings of clinical and radiographic studies on low-level laser therapy (LLLT) in vital pulp therapy

From: The application of lasers in vital pulp therapy: clinical and radiographic outcomes

Author

Study type

Number of teeth

Treatment type

Materials used in vital pulp therapy

Laser characteristics

Follow-up duration

Results

Fernandes et al. [32]

Human in vivo

60 mandibular primary molar teeth

Pulpotomy

FC + ZOE + RMGI

CH + ZOE + RMGI

LLLT + 

CH + ZOE + RMGI

LLLT + 

ZOE + 

RMGI

LLLT

In-Ga-AlP

660 nm

2.5 J/cm2

10 mW

50–60 Hz

10 s

Contact mode

6,12,18 months

Clinical success rate:

100% in all groups over the follow up period

Radiographic success rate after 6,12 and 18 months:(sig.)

FC: 100%,100%,100%

CH: 60%,50%, 66.7%

LLLT: 80%,80%,73.3%

LLLT + CH:85.7%,78.6%,75%

Number of teeth with internal

resorption:

FC < LLLT + CH < LLLT < CH

Hard tissue barrier was seen in CH

groups:

CH < LLLT + CH

Pulp calcification was seen in all groups:

LLLT + CH < FC < CH < LLLT

No hard tissue barrier was observed

in the FC and LLLT groups

Uloopi

et al. [39]

Human in vivo

40 primary molar teeth

Pulpotomy

MTA + GI + 

SS crown

LLLT + GI + SS crown

LLLT

Diode laser

810 nm

CW

2 J/cm2

10 s

3,6,12 months

Overall (Clinical&Radiographic) success rate after 3,6,12

months:(non sig.)

MTA:94.7%,94.7%,94.7%

LLLT:95%,85%,80%

Alamoudi et al. [35]

Human in vivo

106 primary molar teeth

Pulpotomy

FC + IRM + 

SS crown

LLLT + IRM + SS crown

LLLT

Diode laser

810 nm

6.7 J/cm2

40 s

Non-contact (2 mm)

3 W

Continuous mode

6,12 months

Clinical success rate after6,12monthes:(non sig.)

FC:98%, 96.1%

LLLT:98%, 96.1%

Radiographic success rate after 6,12 months:

FC:98%, 98%

LLLT:100%, 100%

Golpayegani et al. [37]

Human in vivo

46 primary molars

pulpotomy

LLLT + ZOE + reinforced ZOE + SS crown

FC + ZOE + reinforced ZOE + SS crown

LLLT

Diode laser

632 nm

Continuous mode/2.5 s

4 J/Cm2

Non contact (2 mm)

6,12 months

Clinical success rate after 6,12 months:

LLLT:100%,89%

FC:100%,100%

Radiographic success rate after 6,12 months:

LLLT:89%,

FC:100%,100%

Ansari et al. [36]

Human in vivo

160 primary molar teeth

pulpotomy

FC + Zonalin + SS crown

FS + Zonalin + SS crown

CEM + 

Zonalin

 + SS crown

LLLT + CEM + Zonalin + SS Crown

LLLT

Diode laser

632 nm

Continuous mode

4 J/cm2

135 s

6,12 months

Clinical success rates after 6,12 months: (non sig.)

FC:100%-100%

FS:97.5%-95%

CEM:100%-97.5%

LLLT + CEM:100%-100%

Radiographic success rate after 6,12 months: (non sig)

FC:100%-100%

FS:97.5%-92.5%

CEM:100%-95%

LLLT + CEM:100%-100%

Yavagal et al. [50]

Human in vivo

68 primary molars

pulpotomy

FC + ZO (Eugenol-free) + GI + 

SS crown

LPBM(LLLT) + GI + 

SS crown

LLLT

Ga-Al-As Diode laser

660-nm

36 mW

Non-contact mode

4 min

8.64 J/cm2

9 months

Clinical success rate: (non sig.)

FC:97.05%

LLLT:94.1%

Radiographic success rate: (sig.)

FC:58.82%

LLLT:94.1%

Nadhreen et al. [49]

Human in vivo

106 primary molars

pulpotomy

LLLT + IRM + 

SS crown

FC + IRM + 

SS Crown

LLLT

Diode lassr

810-nm

4 J

6.7 J/cm2

Non-contact mode

40 s

1-50KHZ

3,9 months

Clinical success rate after 3, 9 months: (non sig.)

LLLT:98%,98%

FC:98%,98%

Radiographic success rate after 9 months: (non sig.)

LLLT:100%

FC:98%

Ebrahimi et al. [20]

Human in vivo

63 primary molar teeth

Partial pulpotomy

MTA

LLLT (Low power diode laser) + MTA

Diode laser(high power) + MTA

LLLT

Diode laser (low power)

660-nm 200mW

Diode laser (high power)

810-nm

1W

6,9,18 months

Clinical success rate: (non sig.)

MTA:100%,100%,100%

LLLT + MTA:100%,100%,100%

Diode laser + MTA:95.2%,95.2%,87.5%

Radiographic success rate after 6,9,18 months:(non-

sig)

MTA:90.5%,90.5%,87.5%

LLLT + MTA:100%,95.2%,88.2%

Diode laser + MTA:85.7%,76.2%,68.7%

Kaya et al. [51]

Human in vivo

172 primary molars

Pulpotomy

LLLt(PBMT)+CH

MTA

CH

FC

LLLT Diode laser

820-nm 10mW

2.5 J/cm2

12s

6,12 months

Clinical & radiographic success rate after 12 months:

LLLT(PBMT) + CH:87%,73%

MTA:97%,95%

CH:71%,45%

FC:97%, 92%